Digital Health in Global

Digital Health Exits in 2026: M&A Dominance, Longer Hold Periods, and Strategic Consolidation

Digital health liquidity remains steady, but the market has changed. For investors, corporates, and ventures, the winning strategy is less about waiting…

June 30, 2026 by Sara Schmachtenberg Read article

Big Tech is no longer experimenting at the edges of healthcare. Microsoft, Amazon, Google, Apple, NVIDIA and Meta are becoming part of healthcare’s infrastructure, AI, data, consumer access and venture partnership layer.

Big Tech is becoming part of the operating system of modern healthcare. From AI and cloud infrastructure to wearables, pharmacy, clinical workflow…

June 15, 2026 by Galen Growth Read article

The Investable Core: Why Investors Are Backing Health Management Solutions in 2026

Roche’s $1.05bn acquisition of PathAI raises new questions around AI infrastructure neutrality, companion diagnostics and vendor governance

June 2, 2026 by Sara Schmachtenberg Read article

The Execution Decade: Why Clinical Trials Are Pharma’s 2026 R&D Bottleneck

IQVIA’s Global Trends in R&D 2026 confirms what the digital health data has been signalling for two years: pharma’s productivity problem lives…

May 7, 2026 by Julien de Salaberry Read article

The Administration Problem: How $5.6B Rewired Health Management Solutions in 2025

Capital didn't just flow into Health Management Solutions in 2025 — 83% of it went to a single thesis: that AI must…

May 5, 2026 by Sara Schmachtenberg Read article

Global Digital Health Ecosystem Q1 2026 Performance Review

Capital, Categories, and the Structural Shifts Defining Digital Health in 2026 TL;DR Global digital health venture funding reached $7.1 billion in Q1…

April 8, 2026 by Galen Growth Read article

Digital health funding in Clinical Trials: Why Execution, Not Discovery, is Pharma’s Next Existential Bottleneck

TL;DR The Bottleneck Has Shifted: TechBio funding surged +75%. Clinical trial funding fell -30%. Trials still consume >50% of total R&D costs.…

March 31, 2026 by Galen Growth Read article

Next Generation Power Players: HealthTech 250 Reveals 50 Emerging Digital Health Startups in Top Clusters

TL;DR A Shortcut to the Next Generation: Amidst a maturing market that saw $29.7 billion in global digital health funding in 2025,…

March 24, 2026 by Galen Growth Read article

The Signal Beneath the Noise: What the 2026 HT250 Tells Investors About Where Digital Health Is Actually Heading

Galen Growth's proprietary ranking of the world's most promising early-stage digital health startups reveals a global sector defined by capital discipline, AI-native…

March 17, 2026 by Galen Growth Read article

Vertical AI in Healthcare: Vertical AI Beats Horizontal in the Agentic AI Era — Why Specialist Intelligence Wins

In the agentic AI era, defensibility shifts from foundation models to vertical data moats. In healthcare, specialist Digital Health Intelligence platforms outperform…

February 24, 2026 by Galen Growth Read article

Digital health exits: fewer fireworks, firmer foundations

Digital health exits reached $13.9bn in 2025, marking a 10.6% year-on-year increase and signaling a shift from volatility to a more disciplined,…

February 17, 2026 by Galen Growth Read article

The Galen Growth HealthTech 250, one year on: separating signal from noise in digital health ventures

One year after selection, the 2025 HealthTech 250 demonstrates exceptional resilience, raising $1.6B, securing 1,001 partnerships, and maintaining a 96% survival rate.…

February 12, 2026 by Galen Growth Read article